Source comparison
SS-31 Dosage Math: Reconstitution Scenarios Comparison
| Vial Size | Purity | Active Mass | Reconstitution Volume | Final Concentration | 2mg Dose Volume | Usable Doses (accounting for dead volume) | Professional Assessment ||—|—|—|—|—|—|—|| 5mg | 96% | 4.8mg | 2mL | 2.4mg/mL | 0.83mL | ~5 doses | Standard protoco
This comparison does not assign a generated winner or score.
- | Vial Size | Purity | Active Mass | Reconstitution Volume | Final Concentration | 2mg Dose Volume | Usable Doses (accounting for dead volume) | Professional Assessment ||—|—|—|—|—|—|—|| 5mg | 96% | 4.8mg | 2mL | 2.4mg/mL | 0.83mL | ~5 doses | Standard protocol. Minimal waste, moderate injection volume, stable for 28 days refrigerated || 5mg | 98% | 4.9mg | 1.5mL | 3.27mg/mL | 0.61mL | ~7 doses | Higher concentration reduces injection volume but increases precipitation risk if stored >30 days || 10mg | 97% | 9.7mg | 4mL | 2.425mg/mL | 0.82mL | ~11 doses | Multi-dose vial. Best for extended protocols, requires strict sterile technique across multiple punctures || 5mg | 95% | 4.75mg | 2.5mL | 1.9mg/mL | 1.05mL | ~4 doses | Lower concentration increases injection volume but maximizes stability. Ideal for sensitive injection sites |